TrialCirculation2021

Finerenone and Cardiovascular Outcomes in Patients With Chronic Kidney Disease and Type 2 Diabetes.

Gerasimos Filippatos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.